Medeon Biodesign, Inc. (TPEX:6499)
82.60
-1.00 (-1.20%)
Apr 20, 2026, 1:24 PM CST
Medeon Biodesign Market Cap
Medeon Biodesign has a market cap or net worth of 8.1 billion as of April 17, 2026. Its market cap has increased by 91.83% in one year.
Market Cap
8.10B
Enterprise Value
7.06B
Revenue
419.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
82.60
Market Cap Chart
Since December 11, 2014, Medeon Biodesign's market cap has increased from 5.77B to 8.10B, an increase of 40.47%. That is a compound annual growth rate of 3.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 8.10B | -7.03% |
| Dec 31, 2025 | 8.72B | 138.60% |
| Dec 31, 2024 | 3.65B | -14.91% |
| Dec 29, 2023 | 4.29B | -15.67% |
| Dec 30, 2022 | 5.09B | -22.76% |
| Dec 30, 2021 | 6.59B | 80.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Visco Vision | 14.81B |
| Vizionfocus | 11.47B |
| Bioteque | 8.28B |
| Formosa Optical Technology | 5.95B |
| Pacific Hospital Supply | 5.88B |
| St.Shine Optical | 5.47B |
| SciVision Biotech | 4.74B |
| Bionime | 4.51B |